Cargando…
Safety and Tolerability of Antiretrovirals during Pregnancy
Combination antiretroviral therapy (CART) dramatically decreases mother-to-child HIV-1 transmission (MTCT), but maternal adverse events are not infrequent. A review of 117 locally followed pregnancies revealed 7 grade ≥3 AEs possibly related to antiretrovirals, including 2 hematologic, 3 hepatic, an...
Autores principales: | Weinberg, Adriana, Forster-Harwood, Jeri, Davies, Jill, McFarland, Elizabeth J., Pappas, Jennifer, Kinzie, Kay, Barr, Emily, Paul, Suzanne, Salbenblatt, Carol, Soda, Elizabeth, Vazquez, Anna, Levin, Myron J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3094700/ https://www.ncbi.nlm.nih.gov/pubmed/21603231 http://dx.doi.org/10.1155/2011/867674 |
Ejemplares similares
-
Kinetics and Determining Factors of the Virologic Response to Antiretrovirals during Pregnancy
por: Weinberg, Adriana, et al.
Publicado: (2009) -
Serious Adverse Events Are Uncommon with Combination Neonatal Antiretroviral Prophylaxis: A Retrospective Case Review
por: Smith, Christiana, et al.
Publicado: (2015) -
Maternal Lopinavir/Ritonavir Is Associated with Fewer Adverse Events in Infants than Nelfinavir or Atazanavir
por: Smith, Christiana, et al.
Publicado: (2016) -
Intrahepatic Cholestasis of Pregnancy and Serum Bile Acids in HIV-Infected Pregnant Women
por: Weinberg, Adriana, et al.
Publicado: (2015) -
Clinical utility and tolerability of linagliptin in diabetic
patients
por: Maxwell, Lauralee Gordon, et al.
Publicado: (2013)